CGT
BIO icon

Capital Guardian Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capital Guardian Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-100
Closed -$20K – 240
2017
Q1 		$20K Hold
100
– – ﹤0.01% 479
2016
Q4 		$18K Hold
100
– – ﹤0.01% 527
2016
Q3 		$16K Hold
100
– – ﹤0.01% 530
2016
Q2 		$14K Hold
100
– – ﹤0.01% 528
2016
Q1 		$14K Hold
100
– – ﹤0.01% 549
2015
Q4 		$14K Hold
100
– – ﹤0.01% 544
2015
Q3 		$13K Hold
100
– – ﹤0.01% 546
2015
Q2 		$15K Hold
100
– – ﹤0.01% 521
2015
Q1 		$14K Buy
+100
New +$12.4K ﹤0.01% 554

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return